APOE and Alzheimer disease: Greater activation in these brain regions were noted acutely at the dorsolateral PFC and temporal cortex [102], presenting significant challenges associated with ApoE4 carriers and, in turn, AD treatment using a ketosis-driven bioenergy supply.